1982
DOI: 10.1530/acta.0.0990546
|View full text |Cite
|
Sign up to set email alerts
|

Treatment with cimetidine in patients with primary hyperparathyroidism

Abstract: Treatment with cimetidine (1000 mg daily in four divided doses) was given for 3\p=n-\20weeks to 10

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1983
1983
1988
1988

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Possibilities which have been explored include therapy with agents thought to reduce PTH secretion such as cimetidine and propranolol 104, 105 and agents thought to blunt the actions of PTH such as diphosphonates and inorganic phosphorus 106–108 . Neither cimeridine nor propranolol has proved effective despite early promising reports 109–114 . Dichloromethylene diphosphonate has been withdrawn from clinical use; therefore, its demonstrated effectiveness cannot be exploited 106, 115 .…”
Section: Medical Managementmentioning
confidence: 99%
“…Possibilities which have been explored include therapy with agents thought to reduce PTH secretion such as cimetidine and propranolol 104, 105 and agents thought to blunt the actions of PTH such as diphosphonates and inorganic phosphorus 106–108 . Neither cimeridine nor propranolol has proved effective despite early promising reports 109–114 . Dichloromethylene diphosphonate has been withdrawn from clinical use; therefore, its demonstrated effectiveness cannot be exploited 106, 115 .…”
Section: Medical Managementmentioning
confidence: 99%